88 related articles for article (PubMed ID: 27282803)
1. Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report.
Fernández de Castillo Torras L; Biterna Tejeiro A; Pla Farnós MJ; Ponce Sebastià J
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():337-8. PubMed ID: 27282803
[No Abstract] [Full Text] [Related]
2. Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
Fernandez H; Schmidt T; Powell M; Costa AP; Arriagada P; Thaler C
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():91-96. PubMed ID: 27898340
[TBL] [Abstract][Full Text] [Related]
3. Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
Modaffari P; D'alonzo M; Garbagnati M; Pecchio S; Menato G; Biglia N
Gynecol Endocrinol; 2018 Mar; 34(3):192-194. PubMed ID: 28933575
[TBL] [Abstract][Full Text] [Related]
4. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
Badiani B; Chiumente M; Messori A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
Brun JL; Rajaonarison J; Froeliger A; Monseau-Thiburce AC; Randriamboavonjy R; Vogler A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():13-18. PubMed ID: 29328939
[TBL] [Abstract][Full Text] [Related]
6. Intravenous leiomyomatosis treated with radical hysterectomy and adjuvant aromatase inhibitor therapy.
Mizoguchi C; Matsumoto H; Nasu K; Arakane M; Kai K; Narahara H
J Obstet Gynaecol Res; 2016 Oct; 42(10):1405-1408. PubMed ID: 27436168
[TBL] [Abstract][Full Text] [Related]
7. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies.
Ciebiera M; Męczekalski B; Łukaszuk K; Jakiel G
Gynecol Endocrinol; 2019 Jun; 35(6):473-477. PubMed ID: 30632825
[TBL] [Abstract][Full Text] [Related]
8. Esmya
Powell M; Dutta D
Womens Health (Lond); 2016 Nov; 12(6):544-548. PubMed ID: 29334010
[TBL] [Abstract][Full Text] [Related]
9. Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis.
Benlolo S; Papillon-Smith J; Murji A
Obstet Gynecol; 2019 Mar; 133(3):434-436. PubMed ID: 30741799
[TBL] [Abstract][Full Text] [Related]
10. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids.
Nagy B; Timár G; Józwiak-Hagymásy J; Kovács G; Merész G; Vámossy I; Ágh T; László Á; Vokó Z; Kaló Z
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():75-81. PubMed ID: 24568866
[TBL] [Abstract][Full Text] [Related]
12. [Ulipristal acetate (Esmya): a selective modulator of progesterone receptors, new treatment of uterine fibromatosis].
Nisolle M; Closon F; Firquet A; Top M; Pintiaux A
Rev Med Liege; 2014 Apr; 69(4):220-5. PubMed ID: 24923103
[TBL] [Abstract][Full Text] [Related]
13. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis].
D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I
Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.
Miura M; Niioka T; Kato S; Kagaya H; Saito M; Habuchi T; Satoh S
Ther Drug Monit; 2011 Jun; 33(3):295-302. PubMed ID: 21572388
[TBL] [Abstract][Full Text] [Related]
15. Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review.
Lewis EI; Chason RJ; DeCherney AH; Armstrong A; Elkas J; Venkatesan AM
Fertil Steril; 2013 Jun; 99(7):2017-24. PubMed ID: 23465706
[TBL] [Abstract][Full Text] [Related]
16. [Ulipristal acetate and SPRM: A new entity for the therapeutic strategy for symptomatic myomas].
Fernandez H
Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):671-672. PubMed ID: 30293948
[No Abstract] [Full Text] [Related]
17. [Ulipristal acetate, 5mg: a new alternative].
Monleón Sancho J; Romaguera E; Romero A; Higueras G; Morcillo I; Fuster S
Med Clin (Barc); 2013 Jul; 141 Suppl 1():40-6. PubMed ID: 24314567
[TBL] [Abstract][Full Text] [Related]
18. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
[TBL] [Abstract][Full Text] [Related]
19. Ulipristal acetate versus placebo for fibroid treatment before surgery.
Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
[TBL] [Abstract][Full Text] [Related]
20. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
